Supreme Court tosses out anti-Amgen ruling in employee case; Big Pharma companies are top MBA recruiters;

@FiercePharma: PetMed marketing overhaul pays off as orders continue to rise in Q3. Article | Follow @FiercePharma

@EricPFierce: EMA suspends Hubei Hongyuan Pharmaceutical after Czech inspectors find dust-covered plant and equipment. ICYMI fron FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: ICYMI: Amgen's Repatha wins first PCSK9 OK in Japan. Article | Follow @CarlyHFierce

> Amgen has scored a victory thanks to the U.S. Supreme Court, which on Monday tossed out a ruling in favor of current and former employees who say they lost money by investing in the pharmaceutical company's own stock-ownership plan. Report

> As the debate over drug prices escalated last year, the pharma industry trade group PhRMA hiked its lobbying spending to $18.32 million, up from $16.51 million in 2014. Report

> Denmark-based Novo Nordisk ($NVO) is staffing up in Iran and continuing work on an expanded manufacturing presence as sanctions lift in the country. Report

> Allergan ($AGN) has won expanded FDA approval for Botox as a treatment for muscle spasticity; the new nod for the drug, best known as a cosmetic treatment, covers muscles in the ankle and toes. Release

> The Philippines' labor secretary has called a meeting between the union and management of Sanofi Aventis, and the medical representatives are calling on the country's Department of Labor and Employment to broker a "fair deal." Report

Medical Device News

@FierceMedDev: U.S. regulators nix $3B Philips lighting sale, complicating HealthTech shift. Article | Follow @FierceMedDev

@EmilyWFierce: It's not bedtime yet for J&J in false advertising lawsuit over baby products. FiercePharmaMarketing story | Follow @EmilyWFierce

> Theranos flagged by CMS for serious problems at California lab: WSJ. More

> German radiosurgery player Brainlab invests $7M+ in Jan Medical for portable concussion Dx. Story

> Wound care company ConvaTec laying off 250 in North Carolina after failing to find M&A suitor. Article

Biotech News

@FierceBiotech: Hedge fund's attack on troubled Zafgen draws blood. Story | Follow @FierceBiotech

@JohnCFierce: $ZFGN down 10% on short attack from Kerrisdale. More | Follow @JohnCFierce

@DamianFierce: the $SRPT cancellation robbed us of a situation in which Ed Kaye and Janet Woodcock are trapped in White Oak and have to unite to survive. | Follow @DamianFierce

> Soon-Shiong's NantCell raises another $57M for immuno-oncology work. Report

> Merck teams with Affimed on immuno-oncology combo. Item

> Editas tests CRISPR/Cas9 enthusiasm--and a turbulent market--with $122M IPO. Article

Animal Health News

> Bird flu losses mount as U.S., Mexico, Canada sign historic pact to control outbreaks. More

> Ceva enters pact with Zoion to develop treatment for dry eye in dogs. Report

> Pharma leaders declare war on antibiotic resistance at Davos. Item

> PetMed marketing overhaul pays off as orders continue to rise in Q3. Story

> Veterinarian turns dog owner's tragedy into cloud-based EHR for pets. Article

Biotech IT News

> BioClinica buys Clinverse to add clinical trial financial management software. More

> GSK scientists accused of data theft in low-tech cybercrime case. Report

> Cedars-Sinai to test Fitbit activity trackers in cancer clinical trial. Item

> Takeda engages Broad for genomic analysis of patient samples from PhIII cancer trial. Story

> Big Pharma consortium rolls out clinical trial investigator platform. Article

Pharma Marketing News

> Synchronized dancers jazz up Reckitt Benckiser's new MegaRed pitch. More

> Fishing for market share, Boehringer Ingelheim casts a new campaign for Pradaxa. Report

> Camera-ready Pfizer and J&J top pharma list of TV ad spenders for 2015. Story

> Oxford Pharmascience scouts marketing partners for new pain meds. Item

> It's not bedtime yet for J&J in false advertising lawsuit over baby products. Article

And Finally... Big Pharma companies are top MBA recruiters, a recent report shows. Report

Suggested Articles

Amid Amgen's pricing war with Sanofi and Regeneron's Praluent, PCSK9 cholesterol fighter Repatha has shown a clinical benefit for HIV patients.

A month after the FDA approved it, Esperion's Nexletol showed it can lower cholesterol regardless of statin and ezitimibe treatment.

AstraZeneca's Farxiga can help prevent worsening or death in heart failure patients regardless of other therapies received, according to new data.